期刊文献+

阿托伐他汀对血管保护作用的研究进展 被引量:7

下载PDF
导出
摘要 动脉粥样硬化(Atherosclemsis,AS)是大多数心脑血管疾病的重要病理基础。阿托伐他汀(atorvastatln)作为一种新型的人工合成降脂药,可降低血浆总胆固醇和低密度脂蛋白胆固醇(LDL—C),并影响机体炎症反应、血管内皮功能、血栓形成等病理生理过程,在延缓动脉粥样硬化进展、减少急性心脑血管事件的发生方面发挥着重要作用。现将阿托伐他汀对血管保护作用的研究进展综述如下。
作者 何坪 殷跃辉
出处 《临床合理用药杂志》 2011年第08X期124-126,共3页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献21

  • 1Trion A,de MaatM,Jukema W,et al.Anti-atherosclerotic effect of amlodipine,alone and in combination with atorvastatin,in APOE * 3-Leiden/hCRP transgenic mice[J].J Canliovasc Pharmacol,2006,47:89-95.
  • 2Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive com-pared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:A randomized controlled trial[J].JAMA,2004,29:1071-1080.
  • 3Mason RP,Walter MF,Day CA,et al.Active metabolite of atorvasta-tin inhibits membrane cholesterol domain formation by an antioxidant mechanism[J].J Biol Chem,2006,281:9337-934S.
  • 4Baigent C,Keech A,Kearney PM.Efficacy and safety of cholesterol-lowering treatment:prospective raeta-analysis of data from 90,056participants in 14 randomised trials of statins[J].Lancet,2005,366:1267-1278.
  • 5Ma QL,Mo L,Yang TL,et al.Effecf of different doses of atorvastatin on adhesion molecules of the patients undergoing percutaneous coronary intervention[J].Zhong Nan Da Xue Xue Bao Yi Xue Ban,2006,31:914 -916.
  • 6Bonetti PO,Lerman LO,Napoli C,et al.Statin effects beyond lipid lowering-are they clinically relevant[J].Eur Heart J,2003,24:225-248.
  • 7Tousoulis D,Antoniades C,Katsi V,et al.The impact of early ad-ministration of low-dose atorvastatin treatment on inflammatory process,in patients with unstable angina and low cholesterol level[J].Int J Cardiol,2006,109:48-52.
  • 8Pearson TA.Mensah GA,Alexander RW,et al.Markers of inflam-mation and cardiovascular disease application to clinical and public health practice:a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association[J].Circulation,2003,107:499-512.
  • 9Llevadot J,Murasawa S,Kureishi Y,et al.HMG-CoA reductase in-hibitor mobilizes bone marrow-derived endothelial progenitor cells[J].J Clin Invest,2001,108:399-405.
  • 10潘殿柱,李永春.阿托伐他汀对低氧大鼠肺血管重建的影响[J].中国全科医学,2005,8(14):1149-1151. 被引量:10

二级参考文献11

  • 1王柏苓,崔松山,杨白玉,周成双,丁万群,孙本韬,王璞,于雪梅,林平,张岩.实验性肺动脉高压及其治疗泡内动脉病变的图像形态定量分析[J].中国医学科学院学报,1996,18(2):147-152. 被引量:3
  • 2孙波 刘文利.右心导管测定大鼠肺动脉压的实验方法[J].中国医学科学院学报,1984,6:465-465.
  • 3杜军保 北京.缺氧性肺动脉高压[M].北京医科大学:中国协和医科大学联合出版社,1994.79.
  • 4Bruemmer D,Yin F,Liu J,et al.Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells[J].Eur J Pharmacol, 2003,462(1):15-23.
  • 5Wassmann S,Laufs U,Baumer AT,et al.HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species[J].Hypertension, 2001,37(6):1450-1457.
  • 6Negre-aminou P,Vliet AK,Erck M,et al.Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors;comparison with other human cell types[J].Biochem Biophys Acta,1997,1345:259-268.
  • 7Vrtovsnik F,Couettes,Prie D,et al.Lovastatin inhibition of renal epithelial tubular cell priliferation involves a P21ras activated AP-1-dependent pathway[J].Kidney Int,1997,52:1016-1017.
  • 8Kano H,Hayashi T,Sumi D,et al.A HMG-CoA reductase inhibitor improved regression of endothelial atherosclerosis in the rabbit aorta without affecting serum lipid levels:possible relevance of upregulation of endothelial NO Synthase mRNA[J].Biochem Biophys Res Commu,1999,259:414-419.
  • 9Narisawa J,Morotomi M,Fukaura Y,et al.Chemoprevention by HMG-CoA reductase inhibitor of N-methyl-N-nitrosoureg induced colon carcinogenesis in F344 Rats[J].Jpn J Cancer Res,1996,87:798-804.
  • 10吴奇志,兰启防,翁南星,林涛.阿托伐他汀钙对急性心肌梗死患者血管内皮细胞功能的影响[J].疑难病杂志,2003,2(1):7-9. 被引量:6

共引文献9

同被引文献71

  • 1钟锦,陈原,熊维建.阿托伐他汀治疗儿童原发性肾病综合征高脂血症1例[J].儿科药学杂志,2005,11(1):50-51. 被引量:3
  • 2王爱民,周颖,肖波,张智博.脑梗死患者血清高敏C反应蛋白水平的变化及其临床意义[J].临床神经病学杂志,2005,18(2):153-154. 被引量:132
  • 3顾东风,Jiang He,吴锡桂,段秀芳,姚崇华,王家良,Kristi Reynolds,Chung-Shiuan Chen,Michael J.Klag,Paul K.Whelton.中国成年人主要死亡原因及其危险因素[J].中国慢性病预防与控制,2006,14(3):149-154. 被引量:75
  • 4孟立军,王文英,刁树玲.阿托伐他汀的临床应用[J].实用心脑肺血管病杂志,2007,15(4):325-326. 被引量:11
  • 5中华医学心血管病分会.关于高血压患者及早启动降压联合他汀的建议[N].中国医学论坛报,2011-9-8(A12).
  • 6Viljoen A. New approaches in the diagnosis of atherosclerosis and treatment of cardiovascular disease [J]. Recent Pecent Pat Cardiovasc Drug Discov, 2008,3(2) :84-91.
  • 7Simpson RJ Jr, Signorovitch J, Bimbaum H. Cardiovascular and eco- nomic outcomes after initiation of lipid - lowering therapy with atorvas- tatinvs simvastatin in an employed population [ J ]. Mayo Clin Proe, 2009,84 (12) : 1065 - 1072.
  • 8Viljoen A. New approaches in the diagnosis of atherosclero- sis and treatment of cardiovascular disease [ J ]. Recent Pat Cardiovasc Drug Discov,2008,3 ( 2 ) : 84 - 91.
  • 9Nicholls SJ, Borgman M, Nissen SE, et al. Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN) [ J ]. Curr Med Res Opin,2011,27(6) :1 119 -1 129.
  • 10Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk [J]. N Engl J Med,2003,348(7) :593 -600.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部